Genes associated with Parkinson's disease: regulation of autophagy and beyond

Journal of Neurochemistry

Volumn , Issue , 2016, Pages 91-107

  Beilina, Alexandra ^a   Cookson, Mark R ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

chaperone mediated autophagy; genetics; lysosomes; mitophagy; Parkinson's disease; protein complexes

Indexed keywords

MEMBRANE PROTEIN; PARKIN; PROTEASOME; PROTEIN SERINE THREONINE KINASE; PTEN INDUCED NOVEL KINASE 1; UBIQUITIN; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; AUTOPHAGY; DOPAMINERGIC SYSTEM; DROSOPHILA; GENE PRODUCT; GENETIC ASSOCIATION; GENETIC REGULATION; GLYCOLYSIS; HOMEOSTASIS; HUMAN; MITOCHONDRIAL MEMBRANE; MITOPHAGY; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84991205640     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13266     Document Type: Review

References (181)

1. Alegre-Abarrategui J., Christian H., Lufino M. M. P., Mutihac R., Venda L. L., Ansorge O. and Wade-Martins R. (2009) LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum. Mol. Genet. 18, 4022–4034.
2. Allen G. F. G., Toth R., James J. and Ganley I. G. (2013) Loss of iron triggers PINK1/Parkin-independent mitophagy. EMBO Rep. 14, 1127–1135.
3. Alvarez-Erviti L., Rodriguez-Oroz M. C., Cooper J. M., Caballero C., Ferrer I., Obeso J. A. and Schapira A. H. V. (2010) Chaperone-mediated autophagy markers in Parkinson disease brains. Arch. Neurol. 67, 1464–1472.
4. Alvarez-Erviti L., Seow Y., Schapira A. H., Rodriguez-Oroz M. C., Obeso J. A. and Cooper J. M. (2013) Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease. Cell Death Dis. 4, e545.
5. Ando M., Funayama M., Li Y. et al. (2012) VPS35 mutation in Japanese patients with typical Parkinson's disease. Mov. Disord. 27, 1413–1417.
6. Anglade P., Vyas S., Javoy-Agid F., Herrero M. T., Michel P. P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E. C. and Agid Y. (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12, 25–31.
7. Ashrafi G., Schlehe J. S., LaVoie M. J. and Schwarz T. L. (2014) Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin. J. Cell Biol. 206, 655–670.
8. Bae E.-J., Lee C., Lee H.-J., Kim S. and Lee S.-J. (2014) ATP13A2/PARK9 Deficiency Neither Cause Lysosomal Impairment Nor Alter α-Synuclein Metabolism in SH-SY5Y Cells. Exp. Neurobiol. 23, 365–371.
9. Bae E.-J., Yang N. Y., Lee C., Lee H.-J., Kim S., Sardi S. P. and Lee S.-J. (2015) Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation. Exp. Mol. Med. 47, e153.
10. Balducci C., Pierguidi L., Persichetti E., Parnetti L., Sbaragli M., Tassi C., Orlacchio A., Calabresi P., Beccari T. and Rossi A. (2007) Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease. Mov. Disord. 22, 1481–1484.
11. Baris H. N., Cohen I. J. and Mistry P. K. (2014) Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history. Pediatr. Endocrinol. Rev. 12(Suppl 1), 72–81.
12. Beilina A., Rudenko I. N., Kaganovich A. et al. (2014) Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease. Proc. Natl Acad. Sci. USA 111, 2626–2631.
13. Birsa N., Norkett R., Wauer T. et al. (2014) Lysine 27 ubiquitination of the mitochondrial transport protein Miro is dependent on serine 65 of the Parkin ubiquitin ligase. J. Biol. Chem. 289, 14569–14582.
14. Biskup S., Moore D. J., Celsi F. et al. (2006) Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann. Neurol. 60, 557–569.
15. Bonifati V. (2012) Autosomal recessive parkinsonism. Parkinsonism Relat. Disord. 18(Suppl 1), S4–S6.
16. Bonifati V. (2014) Genetics of Parkinson's disease–state of the art, 2013. Parkinsonism Relat. Disord. 20(Suppl 1), S23–S28.
17. Bras J. M., Guerreiro R. J., Ribeiro M. H., Januario C., Morgadinho A., Oliveira C. R., Cunha L., Hardy J. and Singleton A. (2005) G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort. Mov. Disord. 20, 1653–1655.
18. Burchell V. S., Nelson D. E., Sanchez-Martinez A. et al. (2013) The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy. Nat. Neurosci. 16, 1257–1265.
19. Cai Q., Zakaria H. M., Simone A. and Sheng Z.-H. (2012) Spatial parkin translocation and degradation of damaged mitochondria via mitophagy in live cortical neurons. Curr. Biol. 22, 545–552.
20. Chan N. C., Salazar A. M., Pham A. H., Sweredoski M. J., Kolawa N. J., Graham R. L. J., Hess S. and Chan D. C. (2011) Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum. Mol. Genet. 20, 1726–1737.
21. Chen L., Xie Z., Turkson S. and Zhuang X. (2015) A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration. J. Neurosci. 35, 890–905.
22. Cherra S. J., Steer E., Gusdon A. M., Kiselyov K. and Chu C. T. (2013) Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons. Am. J. Pathol. 182, 474–484.
23. Chesi A., Kilaru A., Fang X., Cooper A. A. and Gitler A. D. (2012) The role of the Parkinson's disease gene PARK9 in essential cellular pathways and the manganese homeostasis network in yeast. PLoS ONE 7, e34178.
24. Chesser A. S., Pritchard S. M. and Johnson G. V. W. (2013) Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease. Front Neurol. 4, 122.
25. Chinta S. J., Mallajosyula J. K., Rane A. and Andersen J. K. (2010) Mitochondrial α-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci. Lett. 486, 235–239.
26. Chu Y., Dodiya H., Aebischer P., Olanow C. W. and Kordower J. H. (2009) Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions. Neurobiol. Dis. 35, 385–398.
27. Clark I. E., Dodson M. W., Jiang C., Cao J. H., Huh J. R., Seol J. H., Yoo S. J., Hay B. A. and Guo M. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441, 1162–1166.
28. Clayton D. F. and George J. M. (1999) Synucleins in synaptic plasticity and neurodegenerative disorders. J. Neurosci. Res. 58, 120–129.
29. Cookson M. R. (2010) The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Nat. Rev. Neurosci. 11, 791–797.
30. Cookson M. R., Lockhart P. J., McLendon C., O'Farrell C., Schlossmacher M. and Farrer M. J. (2003) RING finger 1 mutations in Parkin produce altered localization of the protein. Hum. Mol. Genet. 12, 2957–2965.
31. Cookson M. R., Hardy J. and Lewis P. A. (2008) Genetic neuropathology of Parkinson's disease. Int. J. Clin. Exp. Pathol. 1, 217–231.
32. Cuervo A. M. and Wong E. (2014) Chaperone-mediated autophagy: roles in disease and aging. Cell Res. 24, 92–104.
33. Cuervo A. M., Stefanis L., Fredenburg R., Lansbury P. T. and Sulzer D. (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305, 1292–1295.
34. Cullen V., Lindfors M., Ng J. et al. (2009) Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Mol. Brain 2, 5.
35. Cullen V., Sardi S. P., Ng J. et al. (2011) Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing. Ann. Neurol. 69, 940–953.
36. Dagda R. K., Cherra S. J., Kulich S. M., Tandon A., Park D. and Chu C. T. (2009) Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J. Biol. Chem. 284, 13843–13855.
37. Dagda R. K., Banerjee T. and Das Janda. E. (2013) How Parkinsonian toxins dysregulate the autophagy machinery. Int. J. Mol. Sci. 14, 22163–22189.
38. Daher J. P. L., Volpicelli-Daley L. A., Blackburn J. P., Moehle M. S. and West A. B. (2014) Abrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats. Proc. Natl Acad. Sci. USA 111, 9289–9294.
39. Daniel G., Musso A., Tsika E., Fiser A., Glauser L., Pletnikova O., Schneider B. L. and Moore D. J. (2014) α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9). Neurobiol. Dis. 73C, 229–243.
40. Deas E., Plun-Favreau H., Gandhi S. et al. (2011) PINK1 cleavage at position A103 by the mitochondrial protease PARL. Hum. Mol. Genet. 20, 867–879.
41. Deng H., Le W., Guo Y., Hunter C. B., Xie W., Huang M. and Jankovic J. (2006) Genetic analysis of LRRK2 mutations in patients with Parkinson disease. J. Neurol. Sci. 251, 102–106.
42. Derivery E., Sousa C., Gautier J. J., Lombard B., Loew D. and Gautreau A. (2009) The Arp2/3 activator WASH controls the fission of endosomes through a large multiprotein complex. Dev. Cell 17, 712–723.
43. Di Fonzo. A., Chien H. F., Socal M. et al. (2007) ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology 68, 1557–1562.
44. Dodson M. W., Zhang T., Jiang C., Chen S. and Guo M. (2012) Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning. Hum. Mol. Genet. 21, 1350–1363.
45. East D. A., Fagiani F., Crosby J., Georgakopoulos N. D., Bertrand H., Schaap M., Fowkes A., Wells G. and Campanella M. (2014) PMI: a ΔΨm independent pharmacological regulator of mitophagy. Chem. Biol. 21, 1585–1596.
46. Farrer M., Kachergus J., Forno L. et al. (2004) Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann. Neurol. 55, 174–179.
47. Feng Y., He D., Yao Z. and Klionsky D. J. (2014) The machinery of macroautophagy. Cell Res. 24, 24–41.
48. Feng Y., Yao Z. and Klionsky D. J. (2015) How to control self-digestion: transcriptional, post-transcriptional, and post-translational regulation of autophagy. Trends Cell Biol. 25, 354–363.
49. Follett J., Norwood S. J., Hamilton N. A. et al. (2014) The Vps35 D620N mutation linked to Parkinson's Disease disrupts the cargo sorting function of retromer. Traffic 15, 230–244.
50. Gegg M. E., Burke D., Heales S. J. R., Cooper J. M., Hardy J., Wood N. W. and Schapira A. H. V. (2012) Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Ann. Neurol. 72, 455–463.
51. Gehrke S., Wu Z., Klinkenberg M., Sun Y., Auburger G., Guo S. and Lu B. (2015) PINK1 and Parkin control localized translation of respiratory chain component mRNAs on mitochondria outer membrane. Cell Metab. 21, 95–108.
52. Gitler A. D., Chesi A., Geddie M. L. et al. (2009) Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat. Genet. 41, 308–315.
53. Gomez T. S. and Billadeau D. D. (2009) A FAM21-containing WASH complex regulates retromer-dependent sorting. Dev. Cell 17, 699–711.
54. Gómez-Suaga P., Rivero-Ríos P., Fdez E., Blanca Ramírez. M., Ferrer I., Aiastui A., López De Munain A. and Hilfiker S. (2014) LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity. Hum. Mol. Genet. 23, 6779–6796.
55. Greene J. C., Whitworth A. J., Kuo I., Andrews L. A., Feany M. B. and Pallanck L. J. (2003) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl Acad. Sci. USA 100, 4078–4083.
56. Greener T., Zhao X., Nojima H., Eisenberg E. and Greene L. E. (2000) Role of cyclin G-associated kinase in uncoating clathrin-coated vesicles from non-neuronal cells. J. Biol. Chem. 275, 1365–1370.
57. Grünewald A., Arns B., Seibler P., Rakovic A., Münchau A., Ramirez A., Sue C. M. and Klein C. (2012) ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome. Neurobiol. Aging 33(1843), e1–e7.
58. Gündüz A., Eken A. G., Bilgiç B., Hanagasi H. A., Bilgüvar K., Günel M., Başak A. N. and Ertan S. (2014) FBXO7-R498X mutation: phenotypic variability from chorea to early onset parkinsonism within a family. Parkinsonism Relat. Disord. 20, 1253–1256.
59. Gusdon A. M., Zhu J., Houten B. and Van Chu. C. T. (2012) ATP13A2 regulates mitochondrial bioenergetics through macroautophagy. Neurobiol. Dis. 45, 962–972.
60. Hardy J. and Lees A. J. (2005) Parkinson's disease: a broken nosology. Mov. Disord. 20(Suppl 12), S2–S4.
61. Heo H. Y., Kim K.-S. and Seol W. (2010) Coordinate Regulation of Neurite Outgrowth by LRRK2 and Its Interactor, Rab5. Exp. Neurobiol. 19, 97–105.
62. Herzig M. C., Kolly C., Persohn E. et al. (2011) LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice. Hum. Mol. Genet. 20, 4209–4223.
63. Hierro A., Rojas A. L., Rojas R., Murthy N., Effantin G., Kajava A. V., Steven A. C., Bonifacino J. S. and Hurley J. H. (2007) Functional architecture of the retromer cargo-recognition complex. Nature 449, 1063–1067.
64. Higashi S., Moore D. J., Yamamoto R., Minegishi M., Sato K., Togo T., Katsuse O. et al. (2009) Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in lewy body disease. J. Neuropathol. Exp. Neurol. 68, 994–1005.
65. Ibáñez P., Bonnet A.-M., Débarges B., Lohmann E., Tison F., Pollak P., Agid Y., Dürr A. and Brice A. (2004) Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 364, 1169–1171.
66. Ikeuchi T., Kakita A., Shiga A. et al. (2008) Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia. Arch. Neurol. 65, 514–519.
67. International Parkinson Disease Genomics Consortium, Nalls M. A., Plagnol V. et al. (2011) Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 377, 641–649.
68. Jin S. M., Lazarou M., Wang C., Kane L. A., Narendra D. P. and Youle R. J. (2010) Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J. Cell Biol. 191, 933–942.
69. Joselin A. P., Hewitt S. J., Callaghan S. M., Kim R. H., Chung Y.-H., Mak T. W., Shen J., Slack R. S. and Park D. S. (2012) ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons. Hum. Mol. Genet. 21, 4888–4903.
70. Kageyama Y., Hoshijima M., Seo K. et al. (2014) Parkin-independent mitophagy requires Drp1 and maintains the integrity of mammalian heart and brain. EMBO J. 33, 2798–2813.
71. Kametaka S., Moriyama K., Burgos P. V., Eisenberg E., Greene L. E., Mattera R. and Bonifacino J. S. (2007) Canonical interaction of cyclin G associated kinase with adaptor protein 1 regulates lysosomal enzyme sorting. Mol. Biol. Cell 18, 2991–3001.
72. Kane L. A., Lazarou M., Fogel A. I., Li Y., Yamano K., Sarraf S. A., Banerjee S. and Youle R. J. (2014) PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J. Cell Biol. 205, 143–153.
73. Kett L. R., Stiller B., Bernath M. M. et al. (2015) α-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2. J. Neurosci. 35, 5724–5742.
74. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y. and Shimizu N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605–608.
75. Komatsu M., Waguri S., Chiba T. et al. (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880–884.
76. Kong S. M. Y., Chan B. K. K., Park J.-S. et al. (2014) Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes. Hum. Mol. Genet. 23, 2816–2833.
77. Koyano F., Okatsu K., Kosako H. et al. (2014) Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510, 162–166.
78. Langston J. W. (2006) The Parkinson's complex: parkinsonism is just the tip of the iceberg. Ann. Neurol. 59, 591–596.
79. Lee D.-W., Wu X., Eisenberg E. and Greene L. E. (2006) Recruitment dynamics of GAK and auxilin to clathrin-coated pits during endocytosis. J. Cell Sci. 119, 3502–3512.
80. Lesage S., Anheim M., Condroyer C. et al. (2011) Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease. Hum. Mol. Genet. 20, 202–210.
81. Li X.-X., Tsoi B., Li Y.-F., Kurihara H. and He R.-R. (2015) Cardiolipin and its different properties in mitophagy and apoptosis. J. Histochem. Cytochem. 63, 301–311.
82. Lin X., Parisiadou L., Gu X.-L. et al. (2009) Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. Neuron 64, 807–827.
83. Linhart R., Wong S. A., Cao J. et al. (2014) Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson's disease mutant of Leucine-rich repeat kinase 2 (LRRK2). Mol. Neurodegener. 9, 23.
84. Liu W., Acín-Peréz R., Geghman K. D., Manfredi G., Lu B. and Li C. (2011) Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission. Proc. Natl Acad. Sci. USA 108, 12920–12924.
85. Liu S., Sawada T., Lee S. et al. (2012) Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria. PLoS Genet. 8, e1002537.
86. Liu L., Sakakibara K., Chen Q. and Okamoto K. (2014) Receptor-mediated mitophagy in yeast and mammalian systems. Cell Res. 24, 787–795.
87. Lonskaya I., Desforges N. M., Hebron M. L. and Moussa C. E.-H. (2013) Ubiquitination increases parkin activity to promote autophagic α-synuclein clearance. PLoS ONE 8, e83914.
88. Lopes da Fonseca T. and Outeiro T. F. (2014) ATP13A2 and Alpha-synuclein: a Metal Taste in Autophagy. Exp. Neurobiol. 23, 314–323.
89. Lwin A., Orvisky E., Goker-Alpan O., LaMarca M. E. and Sidransky E. (2004) Glucocerebrosidase mutations in subjects with parkinsonism. Mol. Genet. Metab. 81, 70–73.
90. MacLeod D. A., Rhinn H., Kuwahara T. et al. (2013) RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron 77, 425–439.
91. Mak S. K., McCormack A. L., Manning-Bog A. B., Cuervo A. M. and Di Monte D. A. (2010) Lysosomal Degradation of a-Synuclein in Vivo. J. Biol. Chem. 285, 13621–13629.
92. Manzanillo P. S., Ayres J. S., Watson R. O., Collins A. C., Souza G., Rae C. S., Schneider D. S., Nakamura K., Shiloh M. U. and Cox J. S. (2013) The ubiquitin ligase parkin mediates resistance to intracellular pathogens. Nature 501, 512–516.
93. Manzoni C., Mamais A., Dihanich S., Abeti R., Soutar M. P. M., Plun-Favreau H., Giunti P., Tooze S. A., Bandopadhyay R. and Lewis P. A. (2013a) Inhibition of LRRK2 kinase activity stimulates macroautophagy. Biochim. Biophys. Acta 1833, 2900–2910.
94. Manzoni C., Mamais A., Dihanich S. et al. (2013b) Pathogenic Parkinson's disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation. Biochem. Biophys. Res. Commun. 441, 862–866.
95. Martinez-Vicente M., Talloczy Z., Kaushik S. et al. (2008) Dopamine-modified α-synuclein blocks chaperone-mediated autophagy. J. Clin. Invest. 118, 777–788.
96. Matsuda N., Sato S., Shiba K. et al. (2010) PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J. Cell Biol. 189, 211–221.
97. Mazzulli J. R., Xu Y.-H., Sun Y., Knight A. L., McLean P. J., Caldwell G. A., Sidransky E., Grabowski G. A. and Krainc D. (2011) Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146, 37–52.
98. McCoy M. K., Kaganovich A., Rudenko I. N., Ding J. and Cookson M. R. (2014) Hexokinase activity is required for recruitment of parkin to depolarized mitochondria. Hum. Mol. Genet. 23, 145–156.
99. McGough I. J., Steinberg F., Jia D. et al. (2014) Retromer Binding to FAM21 and the WASH Complex Is Perturbed by the Parkinson Disease-Linked VPS35(D620N) Mutation. Curr. Biol. 24, 1670–1676.
100. Meissner C., Lorenz H., Weihofen A., Selkoe D. J. and Lemberg M. K. (2011) The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking. J. Neurochem. 117, 856–867.
101. Mijaljica D., Prescott M. and Devenish R. J. (2011) Microautophagy in mammalian cells: revisiting a 40-year-old conundrum. Autophagy 7, 673–682.
102. Miller D. W., Hague S. M., Clarimon J., Baptista M., Gwinn-Hardy K., Cookson M. R. and Singleton A. B. (2004) Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 62, 1835–1838.
103. Miura E., Hasegawa T., Konno M. et al. (2014) VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease. Neurobiol. Dis. 71, 1–13.
104. Moehle M. S., Webber P. J., Tse T., Sukar N., Standaert D. G., DeSilva T. M., Cowell R. M. and West A. B. (2012) LRRK2 inhibition attenuates microglial inflammatory responses. J. Neurosci. 32, 1602–1611.
105. Morais V. A., Verstreken P., Roethig A. et al. (2009) Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function. EMBO Mol. Med. 1, 99–111.
106. Morais V. A., Haddad D., Craessaerts K. et al. (2014) PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling. Science 344, 203–207.
107. Murphy K. E., Gysbers A. M., Abbott S. K., Tayebi N., Kim W. S., Sidransky E., Cooper A., Garner B. and Halliday G. M. (2014) Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease. Brain 137, 834–848.
108. Murphy K. E., Gysbers A. M., Abbott S. K., Spiro A. S., Furuta A., Cooper A., Garner B., Kabuta T. and Halliday G. M. (2015) Lysosomal-associated membrane protein 2 Isoforms Are Differentially Affected in Early Parkinson's Disease. Mov. Disord. In press DOI: 10.1002/mds.26141.
109. Nalls M. A., Pankratz N., Lill C. M. et al. (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat. Genet. 46, 989–993.
110. Narendra D., Tanaka A., Suen D.-F. and Youle R. J. (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183, 795–803.
111. Narendra D. P., Jin S. M., Tanaka A., Suen D.-F., Gautier C. A., Shen J., Cookson M. R. and Youle R. J. (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 8, e1000298.
112. Okatsu K., Koyano F., Kimura M. (2015) Phosphorylated ubiquitin chain is the genuine Parkin receptor. J. Cell Biol. 209, 111–128.
113. Ordureau A., Sarraf S. A., Duda D. M. et al. (2014) Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis. Mol. Cell 56, 360–375.
114. Orenstein S. J., Kuo S.-H., Tasset I. et al. (2013) Interplay of LRRK2 with chaperone-mediated autophagy. Nat. Neurosci. 16, 394–406.
115. Ozelius L. J., Senthil G., Saunders-Pullman R. et al. (2006) LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 354, 424–425.
116. Pacelli C., Rasmo D., De Signorile A. et al. (2011) Mitochondrial defect and PGC-1α dysfunction in parkin-associated familial Parkinson's disease. Biochim. Biophys. Acta 1812, 1041–1053.
117. Paisán-Ruíz C., Jain S., Evans E. W. et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595–600.
118. Parganlija D., Klinkenberg M., Domínguez-Bautista J. et al. (2014) Loss of PINK1 impairs stress-induced autophagy and cell survival. PLoS ONE 9, e95288.
119. Park J., Lee S. B., Lee S. et al. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441, 1157–1161.
120. Park J.-S., Koentjoro B., Veivers D., Mackay-Sim A. and Sue C. M. (2014) Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction. Hum. Mol. Genet. 23, 2802–2815.
121. Plowey E. D., Cherra S. J., Liu Y.-J. and Chu C. T. (2008) Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J. Neurochem. 105, 1048–1056.
122. Podhajska A., Musso A., Trancikova A., Stafa K., Moser R., Sonnay S., Glauser L. and Moore D. J. (2012) Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism. PLoS ONE 7, e39942.
123. Pogson J. H., Ivatt R. M., Sanchez-Martinez A., Tufi R., Wilson E., Mortiboys H. and Whitworth A. J. (2014) The complex I subunit NDUFA10 selectively rescues Drosophila pink1 mutants through a mechanism independent of mitophagy. PLoS Genet. 10, e1004815.
124. Polymeropoulos M. H., Lavedan C., Leroy E. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045–2047.
125. Poulopoulos M., Levy O. A. and Alcalay R. N. (2012) The neuropathology of genetic Parkinson's disease. Mov. Disord. 27, 831–842.
126. Qiao L., Hamamichi S., Caldwell K. A. et al. (2008) Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Mol. Brain 1, 17.
127. Ramirez A., Heimbach A., Gründemann J. et al. (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38, 1184–1191.
128. Ramonet D., Daher J. P. L., Lin B. M. et al. (2011) Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. PLoS ONE 6, e18568.
129. Ramonet D., Podhajska A., Stafa K., Sonnay S., Trancikova A., Tsika E., Pletnikova O., Troncoso J. C., Glauser L. and Moore D. J. (2012) PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity. Hum. Mol. Genet. 21, 1725–1743.
130. Rangaraju V., Calloway N. and Ryan T. A. (2014) Activity-driven local ATP synthesis is required for synaptic function. Cell 156, 825–835.
131. Reinhardt P., Schmid B., Burbulla L. F. et al. (2013) Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell 12, 354–367.
132. Saita S., Shirane M. and Nakayama K. I. (2013) Selective escape of proteins from the mitochondria during mitophagy. Nat. Commun. 4, 1410.
133. Sala G., Stefanoni G., Arosio A., Riva C., Melchionda L., Saracchi E., Fermi S., Brighina L. and Ferrarese C. (2014) Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease. Brain Res. 1546, 46–52.
134. Sánchez-Danés A., Richaud-Patin Y., Carballo-Carbajal I. et al. (2012) Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. EMBO Mol. Med. 4, 380–395.
135. Sarraf S. A., Raman M., Guarani-Pereira V., Sowa M. E., Huttlin E. L., Gygi S. P. and Harper J. W. (2013) Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 496, 372–376.
136. Scarffe L. A., Stevens D. A., Dawson V. L. and Dawson T. M. (2014) Parkin and PINK1: much more than mitophagy. Trends Neurosci. 37, 315–324.
137. Schöndorf D. C., Aureli M., McAllister F. E. et al. (2014) iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis. Nat. Commun. 5, 4028.
138. Schultheis P. J., Fleming S. M., Clippinger A. K. et al. (2013) Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits. Hum. Mol. Genet. 22, 2067–2082.
139. Seaman M. N. J. (2004) Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer. J. Cell Biol. 165, 111–122.
140. Seaman M. N., Marcusson E. G., Cereghino J. L. and Emr S. D. (1997) Endosome to Golgi retrieval of the vacuolar protein sorting receptor, Vps10p, requires the function of the VPS29, VPS30, and VPS35 gene products. J. Cell Biol. 137, 79–92.
141. Sekine S., Kanamaru Y., Koike M. et al. (2012) Rhomboid protease PARL mediates the mitochondrial membrane potential loss-induced cleavage of PGAM5. J. Biol. Chem. 287, 34635–34645.
142. Sevlever D., Jiang P. and Yen S.-H. C. (2008) Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species. Biochemistry 47, 9678–9687.
143. Sharma M., Ioannidis J. P. A., Aasly J. O. et al. (2012) Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology 79, 659–667.
144. Shin N., Jeong H., Kwon J. et al. (2008) LRRK2 regulates synaptic vesicle endocytosis. Exp. Cell Res. 314, 2055–2065.
145. Shin J.-H., Ko H. S., Kang H., Lee Y., Lee Y.-I., Pletinkova O., Troconso J. C., Dawson V. L. and Dawson T. M. (2011) PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease. Cell 144, 689–702.
146. Sidransky E., Nalls M. A., Aasly J. O. et al. (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N. Engl. J. Med. 361, 1651–1661.
147. Simón-Sánchez J., Schulte C., Bras J. M. et al. (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 41, 1308–1312.
148. Singleton A. and Hardy J. (2011) A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci. Hum. Mol. Genet. 20, R158–R162.
149. Singleton A. B., Farrer M., Johnson J. et al. (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science 302, 841.
150. Skibinski G., Nakamura K., Cookson M. R. and Finkbeiner S. (2014) Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies. J. Neurosci. 34, 418–433.
151. Spencer B., Potkar R., Trejo M., Rockenstein E., Patrick C., Gindi R., Adame A., Wyss-Coray T. and Masliah E. (2009) Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J. Neurosci. 29, 13578–13588.
152. Spillantini M. G., Schmidt M. L., Lee V. M., Trojanowski J. Q., Jakes R. and Goedert M. (1997) Alpha-synuclein in Lewy bodies. Nature 388, 839–840.
153. Sterky F. H., Lee S., Wibom R., Olson L. and Larsson N.-G. (2011) Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc. Natl Acad. Sci. USA 108, 12937–12942.
154. Strappazzon F., Nazio F., Corrado M. et al. (2015) AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62/SQSTM1. Cell Death Differ. 22, 419–432.
155. Su Y.-C., Guo X. and Qi X. (2015) Threonine 56 phosphorylation of Bcl-2 is required for LRRK2 G2019S-induced mitochondrial depolarization and autophagy. Biochim. Biophys. Acta 1852, 12–21.
156. Taymans J.-M. and Cookson M. R. (2010) Mechanisms in dominant parkinsonism: the toxic triangle of LRRK2, alpha-synuclein, and tau. BioEssays 32, 227–235.
157. Tong Y., Giaime E., Yamaguchi H., Ichimura T., Liu Y., Si H., Cai H., Bonventre J. V. and Shen J. (2012) Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway. Mol. Neurodegener. 7, 2.
158. Tsika E., Glauser L., Moser R. et al. (2014) Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration. Hum. Mol. Genet. 23, 4621–4638.
159. 2+ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation. Hum. Mol. Genet. 23, 2791–2801.
160. Valente E. M., Abou-Sleiman P. M., Caputo V. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158–1160.
161. Van Laar V. S., Arnold B., Cassady S. J., Chu C. T., Burton E. A. and Berman S. B. (2011) Bioenergetics of neurons inhibit the translocation response of Parkin following rapid mitochondrial depolarization. Hum. Mol. Genet. 20, 927–940.
162. Van Laar V. S., Roy N., Liu A., Rajprohat S., Arnold B., Dukes A. A., Holbein C. D. and Berman S. B. (2015) Glutamate excitotoxicity in neurons triggers mitochondrial and endoplasmic reticulum accumulation of Parkin, and in the presence of N-acetyl cysteine, mitophagy. Neurobiol. Dis. 74, 180–193.
163. Vilariño-Güell C., Wider C., Ross O. A. et al. (2011) VPS35 Mutations in Parkinson Disease. Am. J. Hum. Genet. 89, 162–167.
164. Vincow E. S., Merrihew G., Thomas R. E., Shulman N. J., Beyer R. P., MacCoss M. J. and Pallanck L. J. (2013) The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo. Proc. Natl Acad. Sci. USA 110, 6400–6405.
165. Vives-Bauza C., Zhou C., Huang Y. et al. (2010) PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc. Natl Acad. Sci. USA 107, 378–383.
166. Vogiatzi T., Xilouri M., Vekrellis K. and Stefanis L. (2008) Wild type α-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J. Biol. Chem. 283, 23542–23556.
167. Webb J. L., Ravikumar B., Atkins J., Skepper J. N. and Rubinsztein D. C. (2003) Alpha-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278, 25009–25013.
168. Weihofen A., Thomas K. J., Ostaszewski B. L., Cookson M. R. and Selkoe D. J. (2009) Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking. Biochemistry 48, 2045–2052.
169. Wu G., Huang J., Feng X. et al. (2011a) Decreased expression of lysosomal alpha-galactosiase A gene in sporadic Parkinson's disease. Neurochem. Res. 36, 1939–1944.
170. Wu G., Wang X., Feng X. et al. (2011b) Altered expression of autophagic genes in the peripheral leukocytes of patients with sporadic Parkinson's disease. Brain Res. 1394, 105–111.
171. Xilouri M., Vogiatzi T., Vekrellis K., Park D. and Stefanis L. (2009) Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy. PLoS ONE 4, e5515.
172. Yan J. (2014) Interplay between HDAC6 and its interacting partners: essential roles in the aggresome-autophagy pathway and neurodegenerative diseases. DNA Cell Biol. 33, 567–580.
173. Ye X., Sun X., Starovoytov V. and Cai Q. (2015) Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer's disease patient brains. Hum. Mol. Genet. 24, 2938–2951.
174. Youle R. J. and Narendra D. P. (2011) Mechanisms of mitophagy. Nat. Rev. Mol. Cell Biol. 12, 9–14.
175. Young A. R. J., Chan E. Y. W., Hu X. W., Köchl R., Crawshaw S. G., High S., Hailey D. W., Lippincott-Schwartz J. and Tooze S. A. (2006) Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes. J. Cell Sci. 119, 3888–3900.
176. Yun H. J., Kim H., Ga I., Oh H., Ho D. H., Kim J., Seo H., Son I. and Seol W. (2015) An early endosome regulator, Rab5b, is an LRRK2 kinase substrate. J. Biochem. 157, 485–495.
177. Zavodszky E., Seaman M. N. J., Moreau K., Jimenez-Sanchez M., Breusegem S. Y., Harbour M. E. and Rubinsztein D. C. (2014) Mutation in VPS35 associated with Parkinson's disease impairs WASH complex association and inhibits autophagy. Nat. Commun. 5, 3828.
178. Zhang H. and Baehrecke E. H. (2015) Eaten alive: novel insights into autophagy from multicellular model systems. Trends Cell Biol. 7, 376–387.
179. Zhao X., Greener T., Al-Hasani H., Cushman S. W., Eisenberg E. and Greene L. E. (2001) Expression of auxilin or AP180 inhibits endocytosis by mislocalizing clathrin: evidence for formation of nascent pits containing AP1 or AP2 but not clathrin. J. Cell Sci. 114, 353–365.
180. Zimprich A., Biskup S., Leitner P. et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601–607.
181. Zimprich A., Benet-Pagès A., Struhal W. et al. (2011) A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet. 89, 168–175.